Celula Receives $15,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    5820 Nancy Ridge Drive San Diego, CA 92121
  • Company Description
    Celula develops innovative instruments for personalized diagnostics using advanced microfluidics and other technologies. Using its platforms, Celula alone and in collaborations with industry and academia, identifies, develops, and validates unique cutting edge assays with broad biomedical research and clinical utility. Our devices and assays are developed to make a unique and positive impact on medical outcomes, and create value for all our stakeholders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Skyline Ventures
  • Venture Investor
    Enterprise Partners Venture Capital
  • Venture Investor
    Versant Ventures

Trending on Xconomy